1 / 9

Charlotte Unger Scientific Director Environment Medical Products Agency Sweden

Commission from the Swedish Government - investigate the possibilities to improve the environmental requirements. Charlotte Unger Scientific Director Environment Medical Products Agency Sweden. Govermental Commission Background.

rhonda
Télécharger la présentation

Charlotte Unger Scientific Director Environment Medical Products Agency Sweden

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Commission from the Swedish Government - investigate the possibilities to improve the environmental requirements Charlotte Unger Scientific Director Environment Medical Products Agency Sweden

  2. Govermental Commission Background • High concentrations of pharmaceuticals have been detected in surface, ground, and drinking water near production area • This raises serious concerns regarding the development of antibiotic resistance, and it creates a major challenge for producers and regulatory agencies to improve the situation

  3. Goverment Commission • The Swedish MPA should, after consultation with the Swedish EPA and the Swedish Chemical Agency, investigate the possibilities to improve the environmental requirements regarding the production of pharmaceuticals and active pharmaceutical ingredients, nationally as well as internationally.

  4. Goverment Commission • Possibility for improvement in the environmental requirements, both legislative as well as voluntary initiatives from the industry sector and/or global initiatives on UN-level, should be investigated. Alternative ways of action should be proposed, and the MPA should recommend one of these. • To be reported 31 Dec 2009.

  5. A sustainable production • The Picture of Production • What is done on a voluntary basis • Current legislation and application • Conditions for Changes • Summary and Recommendations

  6. Good examples on a voluntary basics • Work is preformed on different levels • Environmental management systems • Clean Technologies • Green Chemistry • Pharmaceutical Supply Chain Initiatives • International agreements

  7. Legislation and Guidelines • Pharmaceuticals – approval of pharmaceutical, god manufacturing practice • Environment – Reach, Water framework directive, Integrated Pollution Prevention and Control directive, Environmental consequences, Stockholm Convention • Convention on human rights

  8. Conditions for changes • Sustainable development is an UN cornerstone and is also an overall objective of the EU Treaty since ten years. • The policies stress the importance of coherent actions within and between different policy areas.

  9. Summary and recommendations to the Government- to be reported... • MPA is planning to present the report to the Government before Christmas • English summary to be sent to all

More Related